Search

Fourth-year student Yvonne Gruber was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation.

Gerstner Sloan Kettering welcomed its sixth class of PhD students on July 25, 2011. The incoming class is composed of three women and seven men.

New research of metastatic pancreatic cancer has shown that the same mutations are involved in driving both the primary tumor and the metastases.

Scientists at the Sloan Kettering Institute have identified a fundamentally new type of protein-sorting system in cells.

Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face.

By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care.

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.